We are thrilled to share some exciting news with you! Our innovative work in the field of space health research has been prominently featured as – not one, but two groundbreaking papers – in the latest edition of Nature. These full edition papers focus on decentralized research in space missions and the significant impacts of space travel on human health, showcasing data collected using our cutting-edge technology platform. We are proud to have been the technology partner selected to collect, manage, and analyze this invaluable data. Learn more.
What’s new at TrialX?
📢 PRESS RELEASE
We are excited to announce the launch of an innovative AI based Clinical Trial Finder tool on www.TrialX.com, showcasing a host of features designed to simplify access to clinical trial information for all audiences. Leveraging recent advancements in AI technology, the tool revolutionizes the way users navigate and comprehend complex clinical trial information.
🧑💻️ CONFERENCE UPDATES
The DIA 2024 conference wrapped up on a high note with over 4,000 attendees, 220 sessions, and more than 500 speakers. TrialX stole the show at Booth #1033 with our innovative clinical trial management solutions and the crowd-pleasing “Songs for the Unsung Hero” initiative. Despite a slower event pace compared to previous years, we made a significant impact. Highlights included the exciting launch of our AI-powered clinical trial finder tool and the publication of two groundbreaking papers in Nature, focusing on decentralized clinical research in space missions. Key themes at DIA 2024 spotlighted the transformative power of AI in drug development, the importance of patient engagement, and the necessity for regulatory agility. Discussions also covered diversity, patient-centric approaches, and inclusive trial design. The conference underscored the value of collaboration, technology integration, and amplifying the patient voice to drive forward global healthcare solutions. Read more.
RECENT CURETALKS 
Breast cancer recurrence, often occurring years after initial treatment, poses a significant challenge to patients and caregivers. Recent research suggests that targeting dormant tumor cells before they can trigger recurrence may be a promising approach to prevent relapse. Watch Dr. Angela DeMichele of the University of Pennsylvania share why breast cancers recur and discuss approaches being investigated to prevent relapse with patient advocate Heidi Floyd. Watch here.
🧬 FEATURED CLINICAL STUDIES
Powered by TrialX
Looking to stretch your food dollars? We can help! Researchers at Purdue University are looking for families to be in a study about the Nutrition Education Program, which provides education to make healthy choices and planning and preparing family meals. Learn more.
ADDS-UP3: Interview Study: Join our ADDS-UP3 (Atopic Dermatitis Disparities Study – University of Pennsylvania & Philadelphia Partnership): Eczema Interview Study! The purpose of this study is to understand your experience living with eczema (also known as atopic dermatitis) and identify the things in your daily life that affect your skin. Learn more.
Cardiac Amyloidosis Discovery Trial: This is a single center, diagnostic clinical trial in which the investigators aim to prospectively validate a deep learning model that identifies patients with features suggestive of cardiac amyloidosis, including transthyretin cardiac amyloidosis (ATTR-CA). Learn more.
Fox Insight – Online Parkinson’s Health and Genetic Study: Fox Insight is an online study gathering health information from tens of thousands of people with and without Parkinson’s disease. Study participation does not require any travel and all you need is an internet connection to start today. Fox Insight volunteers are invited to take part in virtual ‘study visits’ every three months. Learn more.
🌎 NEWS & NOTEWORTHY
📝 New FDA Guidance on Diversity Action Plans
☀️ AI to shield against solar storms
💡 The last 6 decades of AI — and what comes next
🤝 TEAM UPDATES
💼 Job Board
We are looking for a Solutions Specialist, Client Services at TrialX. As a Solutions Specialist, you will be responsible for providing exceptional service to our clients and ensuring their satisfaction with our products and services.
🎶 Clinical Research Songs for the Unsung! 🥳
Our unique “Songs for the Unsung” initiative launched at the DIA 2024 was a resounding success. Over 100 quiet contributors signed up to receive a personalized clinical research song, making our booth one of the most memorable spots at the conference. What better way to celebrate the unsung heroes who contribute to clinical research in countless ways than with a personal song for each?
🤔 Guess The Celebrity?
We decided to have some fun with generative AI and kicked off our TrialX CelebMatch Mixer Challenge. Can you guess the famous face in this AI celebrity mashup as we introduce some of our TrialX team members? Let’s play! (Hint: Rockets) Let’s see your answers in comments here!
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to streamline patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the moon!
